Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?

Lagniau, Sabrina; Lamote, Kevin; van Meerbeeck, Jan P; Vermaelen, Karim Y

Lagniau, Sabrina; Lamote, Kevin; van Meerbeeck, Jan P; Vermaelen, Karim Y.

Afiliação

Lagniau S; Tumor Immunology Laboratory, Department of Respiratory Medicine, Ghent University Hospital, 9000 Ghent, Belgium.
Lamote K; Department of Internal Medicine, Ghent University, 9000 Ghent, Belgium.
van Meerbeeck JP; Tumor Immunology Laboratory, Department of Respiratory Medicine, Ghent University Hospital, 9000 Ghent, Belgium.
Vermaelen KY; Department of Internal Medicine, Ghent University, 9000 Ghent, Belgium.

Oncotarget ; 8(32): 53751-53762, 2017 Aug 08.

Article em En | MEDLINE | ID: mdl-28881848

Palavras-chave

biomarkers; mesothelioma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google